Article
Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
Transplantation proceedings - 1 Oct 2017
Frey A, Ecker E-M, Piras-Straub K, Walker A, Hofmann T G, Timm J, Singer B B, Gerken G, Herzer K
Abstract excerpt
BACKGROUND: The influence of immunosuppressants on hepatitis C virus (HCV) re-infection after liver transplantation, particularly mammalian target of rapamycin inhibitors, remains unclear. The aim of our study was to analyze the influence of everolimus (EVR) on HCV replication activity in the context of underlying molecular mechanisms, with focus on the pro-myelocytic leukemia protein (PML). METHODS: HCV viral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
